Independent provider comparison

Updated September 21, 2026

Maximus vs MEDVi: Which GLP-1 provider is better?

A side-by-side look at total cost, medication format, care, commitment and the situations where each option makes more sense.

By Iacob Pastina, Independent Researcher & Publisher
Reviewed & updated · Cites primary sources (FDA, NEJM, CMS) · Not medical advice
36 providers verified independently·Independent researchHow we rank →

The decision

Which should you choose, Maximus or MEDVi?

Short answer: MEDVi scores higher on our published rubric, 5.7/10 against 5.1/10. Published pricing is not a like-for-like monthly comparison: Maximus is published $79.99/mo; total not verified; MEDVi is $179 first month, then $299/mo.

Consider Maximus if

Men who want GLP-1 alongside testosterone or other men's health protocols.

Consider MEDVi if

Users who want both oral and injectable compounded options in one telehealth program.

Scores follow our published methodology. Partnership status does not change the score or the factual comparison.

Cost

First charge, renewal and commitment

Treatment

Medication, form and approval status

Care

Clinical review and ongoing support

Terms

Cancellation and material cautions

Maximus logo

Maximus

#30 of 36
5.1/10

Best for men who want glp-1 alongside testosterone or other men's health protocols.

Visit Maximus
Higher Rated
MEDVi logo

MEDVi

#25 of 36
5.7/10

Best for users who want both oral and injectable compounded options in one telehealth program.

Visit MEDVi

Side by side

Maximus vs MEDVi at a glance

Compare the price unit as well as the number. A medication-only price, prepaid monthly equivalent and complete recurring program are not the same thing.

FeatureMaximusMEDVi
Why each oneOnly platform offering GLP-1 microdosing from $79.99/mo for BMI as low as 22, targeting the 'small weight loss' and metabolic health market.
A daily dissolvable GLP-1 tablet and a weekly compounded injection in one program, plus brand-name Wegovy and Zepbound on a $99 membership.
Our Score5.1/105.7/10
Headline Pricepublished $79.99/mo; total not verified$179 first month, then $299/mo
Medication TypeBothBoth
Insurance AcceptedNoNo
Best ForMen who want GLP-1 alongside testosterone or other men's health protocols
Users who want both oral and injectable compounded options in one telehealth program
Watch out forThe advertised rates are first cycle prices. Compounded semaglutide steps up from $149.99 to $249.99 a month once the first cycle ends, and tirzepatide from $259.99 to $359.99, with lab work billed on top at $99 for the at-home kit or $19.99 to $115 for a Quest draw
FDA warning letter #721455, issued February 20, 2026, cites misleading labeling and marketing that implied MEDVi compounded the drugs and that compounded products were equivalent to or FDA-evaluated like approved brands. The letter does not allege unsafe medication
Ranking#30#25
Get startedVisit MaximusVisit MEDVi

Trade-offs

Strengths and cautions compared

Maximus

Pros

  • +Advertised starting rate of $79.99/mo for compounded semaglutide, among the lowest headline prices we track; the same page also shows $150 per month, and lab work is billed separately
  • +Compounded plans are flat rate across every dose, so titrating up does not reprice your plan
  • +Maximus adds glycine and B12 to its compounded semaglutide, described on the site as a way to further customize and tailor the medication; it cites no clinical evidence for the combination
1 more documented strengths
  • +Free expedited shipping on all medication orders

Cons

  • −The advertised rates are first cycle prices. Compounded semaglutide steps up from $149.99 to $249.99 a month once the first cycle ends, and tirzepatide from $259.99 to $359.99, with lab work billed on top at $99 for the at-home kit or $19.99 to $115 for a Quest draw
  • −The fulfilling pharmacies are named only as initials in the help center, EVR, FCC or VIOS by state for compounded medication and The Pharmacy Hub for brand-name, and not on the product pages a shopper actually reads
  • −Brand-name plans are priced by dose tier, so titrating up can move you to a higher monthly rate; compounded plans stay flat across all doses
1 more documented cautions
  • −FDA warning letter #730095, issued June 8, 2026, cites false or misleading compounded-GLP-1 marketing claims. It is a marketing/misbranding record, not an unsafe-medication finding

MEDVi

Pros

  • +One of the few compounded providers offering both oral tablets and injectable semaglutide
  • +The landing page says the program is HSA and FSA eligible and includes dietician visits and care coaching, with a footnote making that subject to insurance and copay eligibility
  • +Sleek onboarding experience with clear progress tracking through their patient portal
1 more documented strengths
  • +$179 covers the first month of compounded semaglutide on MEDVi's landing page, including physician review, the personalized plan, medication and free shipping

Cons

  • −FDA warning letter #721455, issued February 20, 2026, cites misleading labeling and marketing that implied MEDVi compounded the drugs and that compounded products were equivalent to or FDA-evaluated like approved brands. The letter does not allege unsafe medication
  • −Its third-party records conflict: 4.3 out of 5 across 14,680 Trustpilot reviews with 12 percent of them at one star, against an F and no accreditation at the BBB
  • −The $179 semaglutide price covers month one only; the FAQ on MEDVi's own landing page says refills are locked in at $299 a month, making the first year $3,468 rather than $2,148
2 more documented cautions
  • −Brand-name Wegovy and Zepbound paths add a $99 membership plus a medication cost the page does not publish, and the same page's hero says "No membership or hidden fees!" directly above those cards; availability is subject to change
  • −No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms

Our Verdict

MEDVi edges out Maximus with a score of 5.7/10 vs 5.1/10. Published pricing is not a like-for-like monthly comparison: Maximus is published $79.99/mo; total not verified; MEDVi is $179 first month, then $299/mo.

Keep narrowing the decision

What should you compare next?

Use the unresolved part of this choice, not a generic related article. These guides own the broader medication, coverage or complete-cost question.

Reviews and pricing sources

Related comparisons

More head-to-head comparisons involving Maximus and MEDVi.

Not comparing, just asking? Quick answers to the most-asked GLP-1 questions →

Not sure which one is right for you?

Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.

Still working out whether either one is above board? We check that separately: is Maximus legit and is MEDVi legit, with the verification evidence behind each answer.